title: Long-term remission after multiple relapses in an elderly patient with lymphomatoid granulomatosis after rituximab and high-dose cytarabine chemotherapy without stem-cell transplantation.
authors.affiliation: Nagoya Daini Red Cross Hospital, Nagoya, Japan.
authors.forename: Tomohiro
authors.initials: T
authors.lastname: Aoki
authors.forename: Yasuhiko
authors.initials: Y
authors.lastname: Harada
authors.forename: Erina
authors.initials: E
authors.lastname: Matsubara
authors.forename: Takanobu
authors.initials: T
authors.lastname: Morishita
authors.forename: Tatsuya
authors.initials: T
authors.lastname: Suzuki
authors.forename: Masanobu
authors.initials: M
authors.lastname: Kasai
authors.forename: Toshiki
authors.initials: T
authors.lastname: Uchida
authors.forename: Toyonori
authors.initials: T
authors.lastname: Tsuzuki
authors.forename: Shigeo
authors.initials: S
authors.lastname: Nakamura
authors.forename: Michinori
authors.initials: M
authors.lastname: Ogura
mesh_terms: D000368:Aged; D058846:Antibodies, Monoclonal, Murine-Derived / Q000008:administration & dosage; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D003561:Cytarabine / Q000008:administration & dosage; D005260:Female; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy* / Q000473:pathology; D008230:Lymphomatoid Granulomatosis / Q000188:drug therapy* / Q000473:pathology; D012008:Recurrence; D000069283:Rituximab
chemical_list: D058846:Antibodies, Monoclonal, Murine-Derived; D003561:Cytarabine; D000069283:Rituximab